BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdelsayed M, Kort EJ, Jovinge S, Mercola M. Repurposing drugs to treat cardiovascular disease in the era of precision medicine. Nat Rev Cardiol. [DOI: 10.1038/s41569-022-00717-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen K, Zeng C. Negative findings but positive contributions in cardiovascular research. Life Sci 2023;:121494. [PMID: 36931498 DOI: 10.1016/j.lfs.2023.121494] [Reference Citation Analysis]
2 Dong Y, Zhai J, Zhang Z, Peng C, Zhang Y, Zhang Z. A regenerable electrochemical sensor for electro-inactive cyclovirobuxine D detection in biological samples. Analyst 2023;148:1265-74. [PMID: 36786730 DOI: 10.1039/d2an01859d] [Reference Citation Analysis]
3 Nelson AR, Christiansen SL, Naegle KM, Saucerman JJ. Logic-based mechanistic machine learning on high-content images reveals how drugs differentially regulate cardiac fibroblasts. bioRxiv 2023:2023. [PMID: 36909540 DOI: 10.1101/2023.03.01.530599] [Reference Citation Analysis]
4 Gianazza E, Brioschi M, Iezzi A, Paglia G, Banfi C. Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges. Int J Mol Sci 2023;24. [PMID: 36834701 DOI: 10.3390/ijms24043291] [Reference Citation Analysis]
5 Todisco S, Musio B, Pesce V, Cavalluzzi MM, Petrosillo G, La Piana G, Sgobba MN, Schlosserová N, Cafferati Beltrame L, Di Lorenzo R, Tragni V, Marzulli D, Guerra L, De Grassi A, Gallo V, Volpicella M, Palese LL, Lentini G, Pierri CL. Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets. Biochem Pharmacol 2023;208:115405. [PMID: 36603686 DOI: 10.1016/j.bcp.2022.115405] [Reference Citation Analysis]
6 Ma Y, Liu C, Cao S, Chen T, Chen G. Microfluidics for diagnosis and treatment of cardiovascular disease. J Mater Chem B 2023;11:546-59. [PMID: 36542463 DOI: 10.1039/d2tb02287g] [Reference Citation Analysis]
7 Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, Liu YS, Zheng G, Zhao JQ, Wei YF, Guo JY, Liu FH, Chang Q, Zhang YX, Liu CG, Zhao YH. The sirtuin family in health and disease. Signal Transduct Target Ther 2022;7:402. [PMID: 36581622 DOI: 10.1038/s41392-022-01257-8] [Reference Citation Analysis]
8 Chaffey L, Roberti A, Greaves DR. Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities. Front Pharmacol 2022;13:1046406. [DOI: 10.3389/fphar.2022.1046406] [Reference Citation Analysis]
9 Chu H, Qin Z, Ma J, Xie Y, Shi H, Gu J, Shi B. Calcium-Sensing Receptor (CaSR)-Mediated Intracellular Communication in Cardiovascular Diseases. Cells 2022;11:3075. [PMID: 36231037 DOI: 10.3390/cells11193075] [Reference Citation Analysis]
10 Hong CC. The grand challenge of discovering new cardiovascular drugs. Front Drug Discov 2022;2. [DOI: 10.3389/fddsv.2022.1027401] [Reference Citation Analysis]